Clinical studies would help develop medical treatments

Mexico City, June 11, 2024.- Currently, Mexico is positioned as the second most important market in the pharmaceutical area in all of Latin America, which has generated great interest among scientists and researchers to develop new treatments that contribute to health. world in our country.

Cofepris has emphasized that conducting medical research in the country is important to develop new treatments that are safe and effective in preventing or detecting diseases. Given this, Examedi has committed to contributing to the health of millions of people with its clinical studies, detecting 600 people with high cholesterol per month; 240 people with high sugar and 160 with thyroid problems thanks to the fact that more than 1,000 studies are carried out per month, which serve to develop treatments for these diseases.

“From the beginning, we have sought to contribute to global health, in the particular case of Mexico we have carried out more than 24 thousand studies over 2 years. With which, we have already been able to detect and prevent approximately 1000 patients per month with diseases with high cholesterol, high sugar and thyroid problems. It is important to emphasize that the data is only used for a scientific purpose and to benefit the industry”commented Juan Pablo Zepeda, Co-founder and COO of Examedi.

The medical or clinical research carried out in the country, and which generally focuses on treating or solving diseases where the Mexican population suffers the most, could focus on creating treatments for diabetes, high cholesterol and thyroid, in addition to oncology and infectious diseases. mostly.

Thanks to genetics and the history of clinical studies of Mexicans, correct research can be achieved. The contribution of clinical studies is vital so that researchers can carry out practices and review quantitative results that are reflected in new discoveries that can become global.

“The number of population in Mexico favors these studies, since it amounts to more than 126 million inhabitants, which generates a lot of data for research and to be able to feed the statistics that can result in a new treatment for some disease, which helps not only to the Mexican population, but also to the world population”concluded the manager.